G. Rosti

Outcome of Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Based On Early Molecular Response and Factors Associated with Early Response: 4-Year Follow-up Data From Enestnd (Evaluating Nilotinib Efficacy and Safety in Clinical Trials Newly Diagnosed Patients)

R. Larson, H. Kantarjian, G. Saglio, 2012 .

Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.

G. Martinelli, G. Saglio, E. Ottaviani, 2000, Haematologica.

Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo).

A. Bosi, A. Pession, F. Locatelli, 1996, Anticancer research.

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients

N. Kröger, A. Zander, H. Wandt, 2003, Bone Marrow Transplantation.

THE USE OF GRANULOCYTIC COLONY-STIMULATING FACTORS IN PATIENTS RECEIVING CHEMOTHERAPY FOR GERM CELL TUMORS

S. Secondino, F. Pasi, B. Filippi, 2021 .

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy

M. Baccarani, G. Martinelli, G. Saglio, 2000, Bone Marrow Transplantation.

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study

R. Foà, R. Latagliata, G. Saglio, 2023, Frontiers in Pharmacology.